Enadoline hydrochloride

General description Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards Application

The (S)-enantiomer of medetomidine, an imidazole compound that binds to &alpha2-adrenoceptors (Ki = 1.08 nM) with high affinity and selectivity its activation of &alpha2-adrenoceptors produces analgesic, sedative, and anxiolytic effects.

The (S)-enantiomer of medetomidine, an imidazole compound that binds to &alpha2-adrenoceptors (Ki = 1.08 nM) with high affinity and selectivity its activation of &alpha2-adrenoceptors produces analgesic, sedative, and anxiolytic effects.

The (S)-enantiomer of medetomidine, an imidazole compound that binds to &alpha2-adrenoceptors (Ki = 1.08 nM) with high affinity and selectivity its activation of &alpha2-adrenoceptors produces analgesic, sedative, and anxiolytic effects.

Enfenamic acid is a nonsteroidal anti-inflammatory agent and a prostaglandin synthetase inhibitor, inhibiting hepatic gluconeogenesis in Swiss albino mice. Enfenamic acid suppresses wound healing.

Enfenamic acid is a nonsteroidal anti-inflammatory agent and a prostaglandin synthetase inhibitor, inhibiting hepatic gluconeogenesis in Swiss albino mice. Enfenamic acid suppresses wound healing.

Enfenamic acid is a nonsteroidal anti-inflammatory agent and a prostaglandin synthetase inhibitor, inhibiting hepatic gluconeogenesis in Swiss albino mice. Enfenamic acid suppresses wound healing.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the

InformationEST73502 hydrochloride is a dual μ-opioid receptor agonist and σ1 receptor antagonist and is used as a clinical candidate for the treatment of pain.

InformationEST73502 hydrochloride is a dual μ-opioid receptor agonist and σ1 receptor antagonist and is used as a clinical candidate for the treatment of pain.

InformationEST73502 hydrochloride is a dual μ-opioid receptor agonist and σ1 receptor antagonist and is used as a clinical candidate for the treatment of pain.